Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
analogizing, app, appended, attack, authentication, back, bad, Bioengineering, Biomedical, cervical, CISM, cloud, committed, contractor, crucial, cup, cybersecurity, deployment, differentiation, diligence, disallowance, dismissed, dispositive, dramatic, dramatically, Drew, email, endpoint, enroute, escalate, fewer, flat, forthcoming, Foundation, gathered, goal, grantor, GxP, Haynie, highlighting, house, IFM, incorrectly, installed, lbs, Lee, left, leveraging, lost, medium, Melinda, men, mobile, mortality, multifactor, NIBIB, NIH, NIST, ordinarily, overview, panel, phishing, Piper, play, point, predecessor, prejudice, preparatory, RADx, redemption, repayment, roughly, RSV, Sandler, SARAPLEX, smartphone, straightforward, Supreme, swab, tablet, Tanner, TB, testimony, threat, training, transportation, transported, triage, turnaround, unidentified, untreated, upper, vaccination, voluntarily, walk, Winston, women
Removed:
Benson, Brent, CDC, chemistry, classification, commence, comprise, death, disability, disclosing, end, engineering, entrance, expanding, facility, FINRA, hardware, intense, intention, involuntary, leasing, methodology, minimum, modified, noted, Reed, registering, retirement, retrospective, Satterfield, serological, substitution, termination, travel, valid
Filing tables
Filing exhibits
Related press release
Associated CODX transcripts
CODX similar filings
Filing view
External links
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-270628 and No. 333-226835 on Form S-3 and 333-237684 and 333-269350 on Form S-8 of Co-Diagnostics, Inc. of our report dated March 16, 2023, relating to our audit of the consolidated financial statements for the year ended December 31, 2022 which appear in this Annual Report on Form 10-K of Co-Diagnostics, Inc.
/s/ Haynie & Company
Salt Lake City, Utah
March 14, 2024